ArticleInternational journal of transgender health2025
Exploring the universe of HIV post-exposure prophylaxis in trans women: A qualitative analysis of access, use and adherence.
Article in International journal of transgender health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Perspectives on PrEP/PEP Integration in Telehealth Gender-Affirming Care: A Survey of Clients From a National Telehealth Platform.Open forum infectious diseases · 2026Article
- HIV post-exposure prophylaxis (PEP) and PEP-in-pocket (PIP) for women: A rodgers' evolutionary concept analysis.Women's health (London, England)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Post-exposure prophylaxis (PEP) for HIV, a form of emergency prevention, has been available for more than two decades. However, information about its use among trans women, a group disproportionately affected by HIV, is limited. Objective: To explore knowledge, barriers, access facilitators, and use of PEP in trans women. Method: A qualitative study was carried out with 90 trans women in Goiânia, Central-West of Brazil, using semi-structured interviews and analyzed using thematic analysis. Results: Participants had prior knowledge about PEP, although many did not understand its application and effectiveness. Despite knowing there were structural and psychosocial barriers that proved to be significant impediments to access and effective use of PEP. Conclusion: There is a need to develop inclusive public health strategies that meet the needs of trans women to improve access to and use of PEP. Continuing education and awareness initiatives are crucial to dispelling myths and providing accurate information about prophylaxis options. These are essential for both the trans community and health professionals, aiming to reduce the incidence of HIV in this vulnerable and often marginalized group. The implementation of such measures can facilitate greater adherence to PEP, contributing to the health and well-being of trans women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.